Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19.
Paul BalfanzBojan HartmannDirk Müller-WielandMichael KleinesDennis HäcklNils KossackAlexander KerstenChristian CornelissenTobias MüllerAyham DaherRobert StöhrJohannes BickenbachGernot MarxNikolaus MarxMichael DreherPublished in: PloS one (2021)
We have identified early risk markers for a severe clinical course, like ARDS or fatal outcome. This data might help develop a strategy to address new therapeutic options early in patients with COVID-19 and at high risk for fatal outcome.